Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Net Sales Growth

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

OXYGENTA PHARMACEUTICAL Last 5 Year Net Sales Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Net Sales Growth(%) 175.7127.93-48.8016.33279.30

What is the latest Net Sales Growth ratio of OXYGENTA PHARMACEUTICAL ?

The latest Net Sales Growth ratio of OXYGENTA PHARMACEUTICAL is 175.71 based on Mar2025 Standalone results.
Year Net Sales Growth
Mar2025175.71
Mar202427.93
Mar2023-48.80
Mar202216.33
Mar2021279.30

How is Net Sales Growth of OXYGENTA PHARMACEUTICAL Trending?

Years Net Sales Growth % Change
Mar2025 175.71
529.11
Mar2024 27.93
Positive
Mar2023 -48.8
Negative
Mar2022 16.33
-94.15
Mar2021 279.3 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Net Sales Growth ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹200.5 Cr 8.9% 7.1% -31.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,050.0 Cr 1.3% -4.5% -0% Stock Analytics
DIVIS LABORATORIES ₹158,157.0 Cr 1.7% -5.9% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,531.0 Cr 2.6% -5% 25.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,190.0 Cr -0.4% -7% 3.6% Stock Analytics
CIPLA ₹98,892.8 Cr 2.6% -7.4% -16.3% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

8.9%

7.1%

-31.4%

SENSEX

4.8%

-4.2%

0.8%


You may also like the below Video Courses